IP Library Granted Patent US 9,138,400
Granted Patent B2
US 9,138,400 · App. 13/473,174 · Granted Sep 22, 2015

Cosmetic use of skin cell autophagy activators

Inventor: Jean Paufique (Objat, FR)
Assignee: SOCIETE INDUSTRIELLE LIMOUSINE D'APPLICATION BIOLOGIQUE DITE SILAB
A61K8/97A61K8/99A61K36/04A61K36/062A61K36/185A61K36/42A61K36/48A61K36/752A61Q19/08
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,138,400
App. No.
13/473,174
Granted
Sep 22, 2015
Kind
B2
Abstract

The object of the invention is the use in a cosmetic composition of an effective amount of at least one cutaneous cell autophagy activator as a cosmetic active ingredient. The invention also relates to cosmetic compositions that include at least one cutaneous cell autophagy activator as a cosmetic active ingredient 5 and a cosmetic process for detoxifying skin and/or for preventing or combating cutaneous aging.

Claims (25)

1. A cosmetic process for detoxifying the skin and/or for combating cutaneous aging, comprising the topical application on the skin of a composition that comprises at least one activator of the autophagy of cells of the skin,

said cutaneous cell autophagy activator being selected based on the results of a test executed in vitro on a culture of cutaneous cells, the test comprising:

cultivating cutaneous cells, keratinocytes or fibroblasts with a suitable culture medium;

removing the culture medium and replacing the medium with a culture medium comprising a stress agent that induces a nutritive and/or oxidative stress;

providing an active ingredient to be tested, said ingredient originating from a plant, algae or yeast;

removing the culture medium comprising the stress agent and replacing the medium with a culture medium comprising the active ingredient;

analyzing the expression of at least one of MAP-LC3, ATG5-12, phosphorylated mTOR, phosphorylated protein p53, DRAM and AMPK by the cultured cutaneous cells;

comparing the results of said analysis with results obtained on a control culture of the cutaneous cells that are not treated with the active ingredient; and

selecting an active ingredient that has at least one of the following activities:

a stimulating activity on expression of MAP-LC3,

a stimulating activity on expression of ATG5-12,

a stimulating activity on expression of phosphorylated protein p53,

a stimulating activity on expression of DRAM,

a stimulating activity on expression of AMPK, and

an inhibiting activity on expression of phosphorylated mTOR.

2. The cosmetic method according to claim 1 , wherein said cutaneous cell autophagy activator is an active ingredient that has a stimulating activity on expression of MAP-LC3.

3. The cosmetic method according to claim 1 , wherein said cutaneous cell autophagy activator is an active ingredient that has a stimulating activity on expression of ATG5-12.

4. The cosmetic method according to claim 1 , wherein said cutaneous cell autophagy activator is an active ingredient that has a stimulating activity on expression of phosphorylated protein p53.

5. The cosmetic method according to claim 1 , wherein said cutaneous cell autophagy activator is an active ingredient that has a stimulating activity on expression of DRAM.

6. The cosmetic method according to claim 1 , wherein said cutaneous cell autophagy activator is an active ingredient that has a stimulating activity on expression of AMPK.

7. The cosmetic method according to claim 1 , wherein said cutaneous cell autophagy activator is an active ingredient that inhibits activation of phosphorylated mTOR.

8. The cosmetic method according to claim 1 , wherein said cutaneous cell autophagy activator is an active ingredient that originates from at least one algae of type Lithothamnium calcareum , or a plant that is selected from among Melilotus officinalis, Citrus limonum, Lens culinaris, Averrhoa Carambola , and Momordica charantia , or a yeast that is selected from among Candida saitoana and Yarrowia lipolytica.

9. The cosmetic method according to claim 1 , wherein said cutaneous cell autophagy activator is present in said composition in an amount of between 0.1 and 15% by weight relative to total weight of the composition.

10. The cosmetic composition according to claim 1 , wherein said cutaneous cell autophagy activator is present in said composition in an amount of between 1% and 4% by weight relative to the total weight of the composition.

11. The cosmetic method according to claim 1 , wherein said composition is in the form of a cream, gel, lotion, ointment, oil-in-water emulsion, water-in-oil emulsion or suspension.

Assignments (2)
CHANGE OF ADDRESS Recorded Jan 28, 2025
From: SOCIETE INDUSTRIELLE LIMOUSINE D'APPLICATION BIOLOGIQUE
To: SOCIETE INDUSTRIELLE LIMOUSINE D'APPLICATION BIOLOGIQUE
Reel/Frame 070028/0334 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 17, 2012
From: PAUFIQUE, JEAN
To: SOCIETE INDUSTRIELLE LIMOUSINE D'APPLICATION BIOLOGIQUE DITE SILAB
Reel/Frame 028226/0224 →
Priority Claims (1)
FR 08 58308 · Dec 5, 2008 · national
Continuity (2)
Division 13133046
Related Publication 20120225092A1 · Sep 6, 2012